Pharma Journalist -

Alvotech and Fuji Pharma announce that the two companies are entering into an exclusive partnership for the commercialization by Fuji Pharma of Alvotech’s biosimilar portfolio in Japan.…
Read More...

Sobi and Novimmune SA announced that the U.S. Food and Drug Administration (FDA) has approved Gamifant(emapalumab-lzsg), an interferon gamma (IFNγ) blocking antibody for the treatment…
Read More...

Cambrex Corporation announced that it has entered into a definitive agreement to acquire Avista Pharma Solutions (Avista), a contract development, manufacturing, and testing…
Read More...

GlaxoSmithKline plc announced the filing of a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) seeking an additional indication for the use…
Read More...

Immunocore Limited announces it has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery collaboration. Genentech and…
Read More...

Ampersand Capital Partners announced that it has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company NEOMED-LABS. This merger brings together…
Read More...

Innovus Pharmaceuticals announced today that the Company has acquired four branded topical products from Boston Topicals, expanding its retail and e-commerce presence in the Company’s…
Read More...

Merck KGaA, Darmstadt, Germany and software company Palantir Technologies announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower…
Read More...

Roivant Sciences and iNtRON Biotechnology announced that they have entered into a global licensing agreement for SAL200, a novel investigational biologic for the treatment of infectious…
Read More...

CASI Pharmaceuticals announces that it has entered into framework agreements to build a state-of-the-art manufacturing site strategically located in the Wuxi Huishan Economic…
Read More...